Veccia, A.; Dipasquale, M.; Lorenzi, M.; Monteverdi, S.; Kinspergher, S.; Zambotti, E.; Caffo, O.
Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives. Cancers 2025, 17, 668.
https://doi.org/10.3390/cancers17040668
AMA Style
Veccia A, Dipasquale M, Lorenzi M, Monteverdi S, Kinspergher S, Zambotti E, Caffo O.
Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives. Cancers. 2025; 17(4):668.
https://doi.org/10.3390/cancers17040668
Chicago/Turabian Style
Veccia, Antonello, Mariachiara Dipasquale, Martina Lorenzi, Sara Monteverdi, Stefania Kinspergher, Elena Zambotti, and Orazio Caffo.
2025. "Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives" Cancers 17, no. 4: 668.
https://doi.org/10.3390/cancers17040668
APA Style
Veccia, A., Dipasquale, M., Lorenzi, M., Monteverdi, S., Kinspergher, S., Zambotti, E., & Caffo, O.
(2025). Osimertinib in the Treatment of Epidermal Growth Factor Receptor-Mutant Early and Locally Advanced Stages of Non-Small-Cell Lung Cancer: Current Evidence and Future Perspectives. Cancers, 17(4), 668.
https://doi.org/10.3390/cancers17040668
